Latvia Hormones Sales is set to reach $8.96 Million by 2026 from $8.25 Million, is expected to increase 4.3% per year. Since 2017, the market jumped by 6.3% year on year totalising $8,140 Million. Germany, the United Kingdom and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Latvia perform in Hormone?
Forecast: Modulators of the Genital System and Sex Hormones Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Genito Urinary System and Sex Hormones Sales in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Genito Urinary System and Sex Hormones Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Modulators of the Genital System and Sex Hormones Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Genito Urinary System and Sex Hormones Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Modulators of the Genital System and Sex Hormones Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Modulators of the Genital System and Sex Hormones Sales in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research